Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations; Draft Guidance for Industry and Food and Drug Administration Staff; Availability
Published Date: 1/7/2025
Notice
Summary
The FDA just dropped a draft guide to help companies make and sell medical devices with AI software. It explains what info to include so the FDA can check these devices are safe and work well, plus tips on managing them from start to finish. If you’re in the AI medical device game, get ready to share your thoughts by April 7, 2025, before the rules get final—and yes, this could affect your product plans and budgets.
Analyzed Economic Effects
6 provisions identified: 6 benefits, 0 costs, 0 mixed.
Marketing submission documentation guidance
The draft guidance explains what documentation sponsors should include in marketing submissions for devices that include AI-enabled software functions to support FDA's evaluation of safety and effectiveness. It is guidance to help manufacturers prepare the material the FDA will review.
Total product lifecycle (TPLC) recommendations
The draft guidance proposes recommendations for the design, development, and implementation of AI-enabled devices throughout the total product lifecycle (TPLC). Manufacturers may use these recommendations from early development through decommissioning.
Transparency and bias evidence expectations
The draft guidance sets out FDA's current thinking on strategies to address transparency and bias, including collecting evidence to evaluate whether a device benefits relevant demographic groups (for example, race, ethnicity, sex, and age) similarly. The goal is to help ensure AI-enabled devices remain safe and effective for their intended use across groups.
Postmarket performance monitoring plan
The draft guidance proposes an approach to postmarket performance monitoring for AI-enabled devices, including using a performance monitoring plan as a risk mitigation tool. FDA highlights performance monitoring as part of managing device risk after marketing.
Opportunity to comment by April 7, 2025
FDA is accepting public comments on the draft guidance and requests that electronic or written comments be submitted by April 7, 2025 so the Agency can consider them before it begins work on the final guidance. Comments may be submitted via https://www.regulations.gov (Docket No. FDA-2024-D-4488) or as written/paper submissions per the notice.
Draft guidance is nonbinding
The document states the draft guidance, if finalized, will represent FDA's current thinking but is not binding, and that alternative approaches that satisfy statutes and regulations may be used. The draft guidance is not for implementation at this time.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11283 — Notice of Availability of the Record of Decision for the Final Environmental Impact Statement for the Dakota Access Pipeline, Lake Oahe Crossing, North Dakota
The U.S. Army Corps of Engineers has officially decided to allow the Dakota Access Pipeline to cross under Lake Oahe in North Dakota, but with extra safety rules. This affects local communities, the environment, and the pipeline company, ensuring the project moves forward carefully. The decision is now public, so everyone knows the plan and what comes next.
2026-11287 — DNP Select Income Fund Inc., et al.
DNP Select Income Fund and several other investment companies want permission to pay out long-term capital gains more often—up to 12 times a year instead of just once or twice. This change could mean more frequent income for investors in these funds, starting after the SEC reviews and approves the request. If you’re interested, you have until June 29, 2026, to ask for a hearing or share your thoughts.
2026-11309 — 60-Day Notice of Proposed Information Collection: Service Coordinators in Multifamily Housing
HUD wants to collect updated info from service coordinators who help people in multifamily housing. They’re asking for public feedback over the next 60 days before finalizing the forms and rules. This helps make sure funds are used right and keeps support services running smoothly, with no new costs for those involved.
2026-11296 — Notice of Determinations and Request for Comments Concerning Actions in Section 301 Investigations of Acts, Policies, and Practices of Various Economies Related to the Failure To Impose and Effectively Enforce a Prohibition on the Importation of Goods Produced With Forced Labor
The U.S. Trade Representative found that many countries aren’t stopping goods made with forced labor from entering the U.S. To fix this, they’re planning to add extra taxes (tariffs) on products from these countries, with rates between 10% and 12.5%. They’re also offering a special deal for some clothing imports and want your thoughts before finalizing these changes by early July 2026.
2026-11327 — Proposed Revisions to the National Handbook of Conservation Practices
The USDA’s Natural Resources Conservation Service is updating some rules in the National Handbook of Conservation Practices to help farmers and landowners protect the environment better. These changes could affect how conservation projects are planned and done, and the public can share their thoughts until July 6, 2026. No big costs are expected, but the updates aim to make conservation easier and more effective.
2026-11276 — Long Island Rail Road's Request To Amend Its Positive Train Control System
The Long Island Rail Road wants to make some changes to its safety system that helps prevent train crashes, called Positive Train Control (PTC). They asked the government for approval on May 21, 2026, and now the public can share their thoughts until June 25, 2026. These updates aim to keep trains safer without causing delays or extra costs for riders.
Previous / Next Documents
Previous: 2024-31542 — Considerations for the Use of Artificial Intelligence To Support Regulatory Decision-Making for Drug and Biological Products; Draft Guidance for Industry; Availability; Comment Request
The FDA is rolling out a draft guide to help drug and biological product makers use artificial intelligence (AI) safely and smartly when making decisions about their products. This affects companies working on medicines and biologics, aiming to boost safety and quality without slowing things down. Comments on this guide are open until April 7, 2025, so industry folks have time to weigh in before the final rules drop.
Next: 2024-31544 — Recommendations To Reduce the Risk of Transmission of Mycobacterium Tuberculosis by Human Cells, Tissues, and Cellular and Tissue-Based Products; Guidance for Industry; Availability
The FDA just dropped new rules to help companies that handle human cells and tissues keep tuberculosis (TB) from spreading. These rules tell them how to check donors for TB risks and what extra steps to take until better TB tests are ready. This change starts right away and helps protect everyone who gets these medical products without adding big costs.